Literature DB >> 19444248

Drug interactions and the evolution of antibiotic resistance.

Pamela J Yeh1, Matthew J Hegreness, Aviva Presser Aiden, Roy Kishony.   

Abstract

Large-scale, systems biology approaches now allow us to systematically map synergistic and antagonistic interactions between drugs. Consequently, drug antagonism is emerging as a powerful tool to study biological function and relatedness between cellular components as well as to uncover mechanisms of drug action. Furthermore, theoretical models and new experiments suggest that antagonistic interactions between antibiotics can counteract the evolution of drug resistance.

Entities:  

Mesh:

Year:  2009        PMID: 19444248      PMCID: PMC2855488          DOI: 10.1038/nrmicro2133

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  61 in total

1.  Epistatic buffering of fitness loss in yeast double deletion strains.

Authors:  Lukasz Jasnos; Ryszard Korona
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

2.  Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions.

Authors:  Robert P St Onge; Ramamurthy Mani; Julia Oh; Michael Proctor; Eula Fung; Ronald W Davis; Corey Nislow; Frederick P Roth; Guri Giaever
Journal:  Nat Genet       Date:  2007-01-07       Impact factor: 38.330

3.  Functional classification of drugs by properties of their pairwise interactions.

Authors:  Pamela Yeh; Ariane I Tschumi; Roy Kishony
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

4.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

5.  Who's afraid of epistasis?

Authors:  W N Frankel; N J Schork
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

6.  Modular epistasis in yeast metabolism.

Authors:  Daniel Segrè; Alexander Deluna; George M Church; Roy Kishony
Journal:  Nat Genet       Date:  2004-12-12       Impact factor: 38.330

Review 7.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Networks from drug-drug surfaces.

Authors:  Pamela Yeh; Roy Kishony
Journal:  Mol Syst Biol       Date:  2007-02-27       Impact factor: 11.429

9.  Chemical combination effects predict connectivity in biological systems.

Authors:  Joseph Lehár; Grant R Zimmermann; Andrew S Krueger; Raymond A Molnar; Jebediah T Ledell; Adrian M Heilbut; Glenn F Short; Leanne C Giusti; Garry P Nolan; Omar A Magid; Margaret S Lee; Alexis A Borisy; Brent R Stockwell; Curtis T Keith
Journal:  Mol Syst Biol       Date:  2007-02-27       Impact factor: 11.429

10.  High-throughput, quantitative analyses of genetic interactions in E. coli.

Authors:  Athanasios Typas; Robert J Nichols; Deborah A Siegele; Michael Shales; Sean R Collins; Bentley Lim; Hannes Braberg; Natsuko Yamamoto; Rikiya Takeuchi; Barry L Wanner; Hirotada Mori; Jonathan S Weissman; Nevan J Krogan; Carol A Gross
Journal:  Nat Methods       Date:  2008-09       Impact factor: 28.547

View more
  138 in total

1.  Prediction of resistance development against drug combinations by collateral responses to component drugs.

Authors:  Christian Munck; Heidi K Gumpert; Annika I Nilsson Wallin; Harris H Wang; Morten O A Sommer
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

2.  The battle of the SNPs.

Authors:  Tim Downing
Journal:  Nat Rev Microbiol       Date:  2011-12-05       Impact factor: 60.633

3.  The optimal deployment of synergistic antibiotics: a control-theoretic approach.

Authors:  Rafael Peña-Miller; David Lähnemann; Hinrich Schulenburg; Martin Ackermann; Robert Beardmore
Journal:  J R Soc Interface       Date:  2012-05-23       Impact factor: 4.118

Review 4.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

Review 5.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

Review 6.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

Review 7.  Evolution of acquired resistance to anti-cancer therapy.

Authors:  Jasmine Foo; Franziska Michor
Journal:  J Theor Biol       Date:  2014-03-25       Impact factor: 2.691

8.  Phenotypic landscape of a bacterial cell.

Authors:  Robert J Nichols; Saunak Sen; Yoe Jin Choo; Pedro Beltrao; Matylda Zietek; Rachna Chaba; Sueyoung Lee; Krystyna M Kazmierczak; Karis J Lee; Angela Wong; Michael Shales; Susan Lovett; Malcolm E Winkler; Nevan J Krogan; Athanasios Typas; Carol A Gross
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

9.  Bacteria responsive antibacterial surfaces for indwelling device infections.

Authors:  Christian Traba; Jun F Liang
Journal:  J Control Release       Date:  2014-12-04       Impact factor: 9.776

10.  Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase.

Authors:  Maya A Farha; Tomasz L Czarny; Cullen L Myers; Liam J Worrall; Shawn French; Deborah G Conrady; Yang Wang; Eric Oldfield; Natalie C J Strynadka; Eric D Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.